Home :
Games : FDA Approves Amgen's XGEVA(TM) (Denosumab) for the Prevention of Skeletal-Related Events in Patients
FDA Approves Amgen's XGEVA(TM) (Denosumab) for the Prevention of Skeletal-Related Events in Patients
Added On:
Fri 19/Nov/2010
Last Updated:
Fri 19/Nov/2010
Blog Name:
FDA Approves Amgen's XGEVA(TM) (Denosumab) for the Prevention of Skeletal-Related Events in Patients
Description:
FDA Approves Amgen's XGEVA(TM) (Denosumab) for the Prevention of Skeletal-Related Events in Patients
http://mind-your-bet.com:80/feeds/fda-approves-amgens-xgevatm-denosumab-for-the-prevention-of-skeletal-related-events-in-patients-with-bone-739.xml
blog directory 
